Efficacy and tolerability of saxagliptin compared with glimepiride in elderly patients with type 2 diabetes: a randomized, controlled study (GENERATION)

Schernthaner G.; Duran-Garcia S.; Hanefeld M.; Langslet G.; Niskanen L.; Ostgren C. J.; Malvolti E.; Hardy E.

首页> 外文期刊>Diabetes, obesity & metabolism >Efficacy and tolerability of saxagliptin compared with glimepiride in elderly patients with type 2 diabetes: a randomized, controlled study (GENERATION)

【24h】

Efficacy and tolerability of saxagliptin compared with glimepiride in elderly patients with type 2 diabetes: a randomized, controlled study (GENERATION)

机译：沙格列汀与格列美脲相比在老年2型糖尿病患者中的疗效和耐受性：一项随机对照研究（GENERATION）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims: To assess the efficacy and safety of adjunctive saxagliptin vs glimepiride in elderly patients with type 2 diabetes (T2D) and inadequate glycaemic control.

机译：目的：评估沙格列汀与格列美脲辅助治疗在2型糖尿病（T2D）和血糖控制不足的老年患者中的疗效和安全性。

著录项

来源
《Diabetes, obesity & metabolism》 |2015年第7期|共9页
作者
Schernthaner G.; Duran-Garcia S.; Hanefeld M.; Langslet G.; Niskanen L.; Ostgren C. J.; Malvolti E.; Hardy E.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词
dipeptidyl peptidase-4 inhibitor; randomized trial; sulphonylureas; type 2 diabetes;

机译：二肽基肽酶-4抑制剂;随机试验;磺酰脲类;2型糖尿病;

相似文献

外文文献
中文文献
专利

1. Efficacy and tolerability of saxagliptin compared with glimepiride in elderly patients with type 2 diabetes: a randomized, controlled study (GENERATION) [J] . Schernthaner G., Duran-Garcia S., Hanefeld M., Diabetes, obesity & metabolism . 2015,第7期

机译：沙格列汀与格列美脲相比在老年2型糖尿病患者中的疗效和耐受性：一项随机对照研究（GENERATION）
2. Efficacy and safety of saxagliptin compared with acarbose in Chinese patients with type 2 diabetes mellitus uncontrolled on metformin monotherapy: Results of a Phase IV open-label randomized controlled study (the SMART study) [J] . Du Jin, Liang Li, Fang Hui, Diabetes, obesity & metabolism . 2017,第11期

机译：Saxagliptin的疗效和安全性与中国2型糖尿病患者的氨基糖对二甲双胍单疗法的患者：IV相开放标签随机对照研究的结果（智能研究）
3. HARMONY 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metformin [J] . AhrénB., JohnsonS.L., StewartM., Diabetes care . 2014,第8期

机译：和谐3：一项104周的随机，双盲，安慰剂和活性对照试验评估了阿比鲁肽与安慰剂，西他列汀和格列美脲相比在服用二甲双胍的2型糖尿病患者中的有效性和安全性
4. A Randomized, Placebo-Controlled Study of the Efficacy of Cognitive Intervention on Elderly People and on Patient's with Alzheimer's Disease [C] . J.J. Yanguas, C. Buiza, I. Etxeberria, International Conference on Computers Helping People with Special Needs(ICCHP 2006); 20060711-13; Linz(AT) . 2006

机译：认知干预对老年人和阿尔茨海默氏病患者疗效的随机，安慰剂对照研究
5. Diabetes Self-Care Management Behaviors and Barriers to Diabetes Care among Patients with Mental Illness and Type 2 Diabetes, Compared to Those with Type 2 Diabetes Only [D] . Olumba, Appolonia Adaku. 2018

机译：糖尿病在精神疾病和2型糖尿病患者中患糖尿病护理的自我保健管理行为和障碍，与2型糖尿病的患者相比
6. Efficacy and safety of dual add‐on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52‐week randomized active‐controlled trial [O] . Juan P. Frias, Guillermo Gonzalez‐Galvez, Eva Johnsson, -1

机译：使用稳定剂量的二甲双胍联合达格列净与沙格列汀和格列美脲双重联用治疗对2型糖尿病控制不良的患者的疗效和安全性：一项为期52周随机对照研究的结果
7. Efficacy and safety of dual add‐on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52‐week, randomized, active‐controlled trial [O] . Juan P. Frias, Guillermo Gonzalez‐Galvez, Eva Johnsson, 2020

机译：双加入治疗与Dapagliflozin Plus Saxagliptin对稳定剂量的二甲双胍的患者患者的疗效和安全性与肺炎素蛋白在稳定剂量的二甲双胍上的患者中：结果由52周，随机的，主动控制的试验

Efficacy and tolerability of saxagliptin compared with glimepiride in elderly patients with type 2 diabetes: a randomized, controlled study (GENERATION)

摘要

著录项

相似文献

相关主题

期刊订阅